Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population‐based cohort studies

• Published in: United European gastroenterology journal Vol. 9; no. 9; pp. 1057 - 1065
• Main Authors: McPherson, Zachary E., Sørensen, Henrik T., Horváth‐Puhó, Erzsébet, Agar, Ashish, Coroneo, Minas T., White, Andrew, Francis, Ian C., Pasquale, Louis R., Kang, Jae H., Pettersson, Sven, Talley, Nicholas J., McEvoy, Mark A.
• Format: Journal Article
• Language: English
• Published: England John Wiley & Sons, Inc 01.11.2021; John Wiley and Sons Inc
• Subjects: Adult; Age; Aged; Aged, 80 and over; Chronic obstructive pulmonary disease; Classification; Codes; cohort studies; Denmark - epidemiology; Diabetes; Ethnicity; Female; Gender; Glaucoma; Glaucoma - complications; Glaucoma - epidemiology; Health services; Hospitals; Humans; Incidence; Irritable bowel syndrome; Irritable Bowel Syndrome - complications; Male; Middle Aged; Nervous system; Neurogastroenterology; Optic nerve; Original; Patients; Prospective Studies; Regression analysis; risk factor; Risk Factors; Sleep apnea; United Kingdom - epidemiology; Denmark; United Kingdom; United Kingdom > UK; cohort studies; irritable bowel syndrome; risk factor; glaucoma
• ISSN: 2050-6406; 2050-6414
• DOI: 10.1002/ueg2.12136

Objective Irritable bowel syndrome (IBS) is a chronic disorder associated with an abnormal gastrointestinal microbiome. Microbiome–host interactions are known to influence organ function including in the central nervous system; thus, we sought to identify whether IBS may be a risk factor for the development of glaucoma. Design Two prospective cohort studies. Subjects The 1958 United Kingdom Birth Cohort (UKBC; 9091 individuals) and the Danish National Registry of Patients (DNRP; 62,541 individuals with IBS and 625,410 matched general population cohort members). Methods In the UKBC, participants were surveyed throughout life (including at ages 42 and 50). The DNRP contains records of hospital‐based contacts and prescription data from the national prescription database. Main Outcome Measure The main outcome measure was incidence of glaucoma. In the UKBC, incident glaucoma at age 50 (n = 48) was determined through comparison of survey responses at ages 42 and 50 years. In the DNRP, glaucoma was assessed by hospital diagnosis (n = 1510), glaucoma surgery (n = 582) and initiation of glaucoma medications (n = 1674). Results In the UKBC, the odds ratio (OR) of developing glaucoma between ages 42 and 50 in persons with a chronic IBS diagnosis was increased [OR: 5.84, 95% confidence interval (CI): 2.26–15.13]. People with an IBS diagnosis in the DNRP had a hazard ratio (HR) of 1.35 for developing physician‐diagnosed glaucoma (95% CI: 1.16–1.56), an HR of 1.35 for undergoing glaucoma surgery (95% CI: 1.06–1.70) and an HR of 1.19 for initiating glaucoma medication (95% CI: 1.03–1.38). Conclusions In two large European cohort studies, IBS is a risk factor for glaucoma.